Dr. Gillian D. Sanders-Schmidler is a member of the Outcomes Research and Assessment Group within the DCRI and a Professor in the Division of Clinical Pharmacology, Department of Medicine at Duke University Medical Center. Dr. Sanders-Schmidler received her undergraduate degree in Mathematics from Princeton University in 1993 and her doctorate in Medical Informatics from Stanford University in 1998. Dr. Sanders-Schmidler was an Assistant Professor of Medicine at Stanford’s Center for Primary Care and Outcomes Research from 1998 until the fall of 2003 when she joined the faculty at Duke University.
Dr. Sanders-Schmidler's research focuses on the development of evidence-based decision models to evaluate the comparative effectiveness of alternative prevention, treatment, and management strategies for chronic diseases – and the translation of such models into formats/tools that patients, healthcare providers, and policymakers can use in their decision-making process. Dr. Sanders-Schmidler is Past President of the Society for Medical Decision Making (SMDM) and served as Director of Duke’s Evidence-based Practice Center (EPC III) funded by the Agency for Healthcare Research and Quality (AHRQ) from 2009-2013 and of EPC V 2014-2019. She directs Duke’s Evidence Synthesis Group. Dr. Sanders-Schmidler has extensive research expertise in both methodology and application of comparative effectiveness and patient-centered outcomes research and leading collaborative investigator teams to perform successful and high-quality systematic review of the literature. She is currently co-chairing the 2nd Panel for Cost Effectiveness in Health and Medicine